Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2009 1
2010 1
2014 1
2015 1
2016 1
2017 2
2018 1
2019 3
2020 1
2021 7
2022 8
2023 2
2024 6
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for R. hksar
Your search for R. Oksar retrieved no results
CT Imaging for Valvular Interventions.
Wang DD, Villablanca PA, So KC, Cubeddu RJ, O'Neill BP, O'Neill WW. Wang DD, et al. Struct Heart. 2025 May 30;9(7):100667. doi: 10.1016/j.shj.2025.100667. eCollection 2025 Jul. Struct Heart. 2025. PMID: 40704363 Free PMC article. Review.
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Disease and Injury and Risk Factor Collaborators. GBD 2023 Disease and Injury and Risk Factor Collaborators. Lancet. 2025 Oct 18;406(10513):1873-1922. doi: 10.1016/S0140-6736(25)01637-X. Epub 2025 Oct 12. Lancet. 2025. PMID: 41092926 Free PMC article.
Liability for Dispensing Errors in Hong Kong.
Tang C. Tang C. Asian Bioeth Rev. 2021 May 28;13(4):435-462. doi: 10.1007/s41649-021-00175-1. eCollection 2021 Dec. Asian Bioeth Rev. 2021. PMID: 34616497 Free PMC article.
The United Kingdom (UK) case R v Lee (2010) EWCA Crim 1404 resulted in a pharmacist being convicted for an inadvertent dispensing error and paved way for the decriminalisation of such errors by way of a due diligence defence enacted in 2018. ...The primary objective of thi …
The United Kingdom (UK) case R v Lee (2010) EWCA Crim 1404 resulted in a pharmacist being convicted for an inadvertent dispensing err …
Room Temperature Aerobic Peroxidation of Organic Substrates Catalyzed by Cobalt(III) Alkylperoxo Complexes.
Chen Y, Shi H, Lee CS, Yiu SM, Man WL, Lau TC. Chen Y, et al. J Am Chem Soc. 2021 Sep 15;143(36):14445-14450. doi: 10.1021/jacs.1c07158. Epub 2021 Sep 3. J Am Chem Soc. 2021. PMID: 34477359
Here we report a series of highly electrophilic cobalt(III) alkylperoxo complexes, Co(III)(qpy)OOR supported by a planar tetradentate quaterpyridine ligand that can directly abstract H atoms from hydrocarbons (R'H) at ambient conditions (Co(III)(qpy)OOR + R'H Co(II) …
Here we report a series of highly electrophilic cobalt(III) alkylperoxo complexes, Co(III)(qpy)OOR supported by a planar tetradentate quater …
Microglial Deletion of Hrh4 Alleviates Alzheimer's Disease Pathologies by Enhancing Microglial Phagocytosis of Amyloid-β and Tau.
Xu YJ, Wu T, Lo LT, Ko CC, Wang X, Ma CHE. Xu YJ, et al. Adv Sci (Weinh). 2025 Oct 24:e05421. doi: 10.1002/advs.202505421. Online ahead of print. Adv Sci (Weinh). 2025. PMID: 41134085
Transcriptomic analysis identifies VUF6002, a histamine H4 receptor (H(4)R) antagonist, which mimics the beneficial effects of LDIR by promoting microglial activity. ...Collectively, these findings reveal a H(4)R/cAMP/TGF-beta1/Smad3 signaling axis involved in micro …
Transcriptomic analysis identifies VUF6002, a histamine H4 receptor (H(4)R) antagonist, which mimics the beneficial effects of LDIR b …
COVID-19 Vaccination Preferences of University Students and Staff in Hong Kong.
Fung LWY, Zhao J, Yan VKC, Blais JE, Chan JCH, Li STH, Shami JJP, Kwan C, Wei Y, Wong CKH, Li X, Chui CSL, Wan EYF, Lai FTT, Tse S, Cowling BJ, Wong ICK, Chan EW. Fung LWY, et al. JAMA Netw Open. 2022 May 2;5(5):e2212681. doi: 10.1001/jamanetworkopen.2022.12681. JAMA Netw Open. 2022. PMID: 35579895 Free PMC article.
Modelling the heart as a communication system.
Ashikaga H, Aguilar-Rodríguez J, Gorsky S, Lusczek E, Marquitti FM, Thompson B, Wu D, Garland J. Ashikaga H, et al. J R Soc Interface. 2015 Apr 6;12(105):20141201. doi: 10.1098/rsif.2014.1201. J R Soc Interface. 2015. PMID: 25740854 Free PMC article.
Efficacy and safety of herbal medicines intervention for cachexia associated with cancer: A systematic review and meta-analysis.
Chen G, Wang N, Yang R, Wu Y, Liu J, Huang Z, Zhang Z, Huang Y, Zhang C, Chan YT, Feng Y. Chen G, et al. Phytother Res. 2023 Nov;37(11):5243-5278. doi: 10.1002/ptr.7956. Epub 2023 Oct 5. Phytother Res. 2023. PMID: 37795775
The herbs with the best curative effect and their optimal dose were Dioscoreae R. (10 g), Citri R.P. (15 g), Coicis S. (10 g), Ophiopogonis R. (10 g) and Ginseng R.E.R. (20 g). ...
The herbs with the best curative effect and their optimal dose were Dioscoreae R. (10 g), Citri R.P. (15 g), Coicis S. (10 g), …
Pharmacokinetic and Exposure-Response Modeling Support Body Surface Area-Based Dosing of Farletuzumab Ecteribulin in Japanese Patients with Solid Tumors.
Hayato S, Hamuro L, Shimizu T, Yonemori K, Nishio S, Yunokawa M, Yoshida T, Nishio M, Matsumoto K, Takehara K, Hasegawa K, Kozuki T, Hirashima Y, Kato H, Miura T, Nomoto M, Zhao Y, Zhu L, Yasuda S. Hayato S, et al. J Clin Pharmacol. 2025 Jun;65(6):751-762. doi: 10.1002/jcph.6187. Epub 2025 Jan 24. J Clin Pharmacol. 2025. PMID: 39853764 Free PMC article. Clinical Trial.
A pharmacometric assessment evaluated farletuzumab ecteribulin pharmacokinetics and exposure-response (E-R) relationships for efficacy and safety to support dose optimization. Patients received 0.3-1.2 mg/kg of farletuzumab ecteribulin intravenously every 3 weeks. A pharma …
A pharmacometric assessment evaluated farletuzumab ecteribulin pharmacokinetics and exposure-response (E-R) relationships for efficac …
42 results